Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from BONESUPPORT HOLDING AB ( (SE:BONEX) ) is now available.
BONESUPPORT Holding AB reported outcomes from its Annual General Meeting, where shareholders approved the income statements, balance sheets and remuneration report, and granted discharge of liability to the Board and CEO. The meeting also confirmed that no dividend will be paid, with SEK 1.2 billion in available funds carried forward to support future operations.
Shareholders re-elected five Board members, appointed a new director, and kept Lennart Johannson as chairman, while tightening alignment with investors by requiring half of Board fees to be reinvested in company shares. The AGM revised executive pay guidelines to allow higher variable pay for the U.S. commercial head, renewed the mandate to issue up to 10 percent new shares, and authorized buybacks and transfers of up to 10 percent of the company’s own stock to finance acquisitions, adjust capital structure and support incentive programs.
More about BONESUPPORT HOLDING AB
BONESUPPORT Holding AB is a Swedish medical technology company specializing in orthobiologics for managing bone injuries. The company develops and markets bone graft substitutes and related solutions, targeting surgeons and healthcare systems focused on treating complex skeletal defects and trauma.
Average Trading Volume: 351,569
Technical Sentiment Signal: Hold
Current Market Cap: SEK15.06B
For an in-depth examination of BONEX stock, go to TipRanks’ Overview page.